|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| C12N 5/20 | |||
| C07K 14/705 |
| (11) | Number of the document | 2371391 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10183377.0 |
| Date of filing the European patent application | 2004-05-10 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 469211 P | 2003-05-08 | US | |
| 557622 P | 2004-03-29 | US | |
| 557621 P | 2004-03-29 | US | |
| 557620 P | 2004-03-29 | US |
| (72) |
Williams, Marna, US
Tso, Yun J., US
Landolfi, Nicolas F., US
Liu, Gao, US
Powers, David B., US
|
| (73) |
AbbVie Biotherapeutics Inc.,
1500 Seaport Boulevard, Redwood City, CA 94063,
US
|
| (54) | Therapeutic use of anti-CS1 antibodies |
| Therapeutic use of anti-CS1 antibodies |